TREATMENT OF OBESITY USING NON-DAILY ADMINISTRATION OF 6 - 0 - (4 - DIMETHYLAMINOETHOXY) CINNAMOYL FUMAGILLOL

• 1. 使用非每天施用的6-0-(4-二甲基氨基乙氧基)肉桂酰烟曲霉醇治疗肥胖症 [P] . 中国专利： CN103379905A . 2013-10-30
• 2. 6-O-(4-二甲基氨基乙氧基)肉桂酰烟曲霉醇草酸盐的多晶型盐及其制备和使用方法 [P] . 中国专利： CN104350046B . 2016.11.30
• 3. Treatment of Obesity Using Non-Daily Administration of 6-O-(4-Dimethylaminoethoxy) Cinnamoyl Fumagillol [P] . 美国专利： US2018221328A1 . 2018-08-09

  机译： 非每日服用6-O-（4-二甲基氨基乙氧基）肉桂酰基富马吉洛治疗肥胖

• 4. Treatment of Obesity Using Non-Daily Administration of 6-O-(4-Dimethylaminoethoxy) Cinnamoyl Fumagillol [P] . 美国专利： US2016243073A1 . 2016-08-25

  机译： 非每日服用6-O-（4-二甲基氨基乙氧基）肉桂酰基富马吉洛治疗肥胖

• 5. Treatment of obesity using non-daily administration of 6-O-(4-dimethylaminoethoxy) cinnamoyl fumagillol [P] . 美国专利： US9000035B2 . 2015-04-07

  机译： 使用非每日服用6-O-（4-二甲基氨基乙氧基）肉桂酰基烟曲霉酚治疗肥胖

• 1. Could sport be part of pediatric obesity prevention and treatment? Expert conclusions from the 28th European Childhood Obesity Group Congress [J] . Susanne Ring-Dimitriou, Marie-Laure Frelut, Eva Erhardt, 运动与健康科学（英文版） . 2019,第004期
• 2. Oral administration of Rehmannia glutinosa extract for obesity treatment via adiposity and fatty acid binding protein expression in obese rats [J] . Mi-Young Park, Hyun Jung Lee, Da Hyeon Choi, Toxicology and Environmental Health Sciences . 2017,第5期
• 3. Two-week administration of engineered Escherichia coli establishes persistent resistance to diet-induced obesity even without antibiotic pre-treatment [J] . Dosoky Noura S., Chen Zhongyi, Guo Yan, Applied Microbiology and Biotechnology . 2019,第16期
• 4. Chronic Oxytocin Administration as a Treatment Against Impaired Leptin Signaling or Leptin Resistance in Obesity [J] . Jordi Altirriba, Anne-Laure Poher, Fran?oise Rohner-Jeanrenaud Frontiers in Endocrinology . 2015,第2期
• 5. From Body Dissatisfaction to Obesity: How Virtual Reality May Improve Obesity Prevention and Treatment in Adolescents [C] . Giuseppe RIVA, Andrea GAGGIOLI, Antonios DAKANALIS Medicine Meets Virtual Reality . 2013
• 6. The Treatment Effects of Dietary Oils on Diet-Induced Obesity, Lipidemia, and Insulin Resistance in Skeletal Muscle Tissue of Obese Prone Rats [D] . Dunthorne, Karin 2011
• 7. Chronic Oxytocin Administration as a Treatment Against Impaired Leptin Signaling or Leptin Resistance in Obesity [O] . Jordi Altirriba, Anne-Laure Poher, Françoise Rohner-Jeanrenaud 2015
• 8. Chronic Oxytocin Administration as a Treatment Against Impaired Leptin Signaling or Leptin Resistance in Obesity [O] . Altirriba Gutierrez, Jorge, Poher, Anne-Laure, Rohner-Jeanrenaud, Françoise 2015

• 1. Veterans health administration hepatitis B testing and treatment with anti-CD20 antibody administration [J] . Christine M Hunt ,Lauren A Beste ,Elliott Lowy . 世界胃肠病学杂志：英文版 . 2016,第19期
• 2. Long-Term Treatment with an Herbal Formula MCC Ameliorates Obesity-Associated Metabolic Dysfunction in High Fat Diet-Induced Obese Mice: A Comparative Study among MCC and Various Combinations of Its Constituents [J] . Pou Kuan Leong ,Hoi Yan Leung ,Hoi Shan Wong . 中医（英文） . 2014,第1期
• 3. TREATMENT OF OBESITY SIMPLEX WITH KANG LING ANTI-OBESITY MIXTURE [J] . 奚彩昆 ,钱佩琼 ,蒋红玉 . 中医杂志：英文版 . 1990,第2期
• 4. Optimization of Exenatide plus Detemir Treatment for Morbid Obese Patients with Insulin Dependent Diabetes Resistant to Conventional Treatment. Effect of Exenatide on Patients with Mellitus Diabetes Type 2 [J] . Alfonso Lopez Ruiz ,Maria Angeles Nunez Sanchez ,Noelia Victoria Garcia-Talavera Espin . 药理与制药（英文） . 2014,第4期
• 5. 含5，7-二甲基-1，2，4-三唑并1，5-a嘧啶邻甲酰氨基苯甲酰胺类衍生物的合成与生物活性 [C] . 董卫莉 ,徐俊英 ,刘幸海 . 中国化工学会农药专业委员会第十三届年会 . 2008
• 6. n-[4-(4,6二甲基-2-嘧啶氧基)-3-甲基苯基]-N’-[2-(二甲氨基)]苯甲酰脲的抗肿瘤作用及作用机制 [A] . 陈苹苹 . 2015